Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer

Recruiting now · Not applicable

Conditions studied: Lymphedema Arm

In brief

This study aims to evaluate the effectiveness of the Lymphovenous Bypass (LVB) procedure compared to physiotherapy alone as secondary prevention of lymphedema in breast cancer patients undergoing axillary lymph node dissection.

Key facts

Study ID

NCT07233863

Run by

Dharmais National Cancer Center Hospital

People needed

136

Starts

2024-03-18

Expected to finish

2028-03-21

Last updated by the study team

2025-11-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Breast cancer patients aged ≥ 18 years with an ECOG score > 1
• Breast cancer patients with post-axillary lymph node dissection diagnosed with stage 0 and I lymphedema.
• Those who have never undergone lymphedema physiotherapy.

You may not qualify if…

• Patients with dermal backflow before axillary lymph node dissection (ALND).
• Patients with breast cancer lymphedema who are unable to undergo a 24-month follow-up at Dharmais Cancer Hospital.
• Patients with iodine allergy, severe asthma, decreased kidney function, pregnancy, or breastfeeding.

Where it is running

• Dharmais National Cancer Center — Jakarta, Jakarta Special Capital Region, Indonesia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.